Your browser doesn't support javascript.
loading
Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers.
Vitallé, Joana; Terrén, Iñigo; Gamboa-Urquijo, Leire; Orrantia, Ane; Tarancón-Díez, Laura; Genebat, Miguel; Ruiz-Mateos, Ezequiel; Leal, Manuel; García-Obregón, Susana; Zenarruzabeitia, Olatz; Borrego, Francisco.
Afiliación
  • Vitallé J; Immunopathology Group, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.
  • Terrén I; Immunopathology Group, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.
  • Gamboa-Urquijo L; Immunopathology Group, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.
  • Orrantia A; Immunopathology Group, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.
  • Tarancón-Díez L; Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, University of Seville, Consejo Superior de Investigaciones Científicas (CSIC), Sevilla, Spain.
  • Genebat M; Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, University of Seville, Consejo Superior de Investigaciones Científicas (CSIC), Sevilla, Spain.
  • Ruiz-Mateos E; Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, University of Seville, Consejo Superior de Investigaciones Científicas (CSIC), Sevilla, Spain.
  • Leal M; Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, University of Seville, Consejo Superior de Investigaciones Científicas (CSIC), Sevilla, Spain.
  • García-Obregón S; Internal Medicine Service, Santa Ángela de la Cruz Viamed Hospital, Sevilla, Spain.
  • Zenarruzabeitia O; Pediatric Oncology Group, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.
  • Borrego F; Immunopathology Group, Biocruces-Bizkaia Health Research Institute, Barakaldo, Spain.
Front Immunol ; 9: 1709, 2018.
Article en En | MEDLINE | ID: mdl-30083165

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2018 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2018 Tipo del documento: Article País de afiliación: España